Using smart driving technology to detect early signs of cognitive decline in older adults
Official title: Smart driving technology for non-invasive detection of age-related cognitive decline
Funded at Tf Health Corporation · NIH-10484798 · Data updated 2026-11-12
This study is looking at how smart driving technology can help spot early signs of memory and thinking problems in older adults, so they can get support before things get worse.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tf Health Corporation NIH-funded |
| Lab location | 1 site (Fountain Hills, United States) |
| Project start | August 15, 2022 |
| Project end | July 31, 2025 |
| Funding year | 2022 |
| Award (this year) | $449,954 |
| NIH project number | 1R43AG078063-01 |
| Project ID | NIH-10484798 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults aged 65 and above who may be experiencing early signs of cognitive decline or Mild Cognitive Impairment.
✕Less likely to help
Patients who are not experiencing any cognitive decline or who are under 65 years old may not benefit from this research.
What this research studies
This research investigates how smart driving technology can be used to identify early signs of cognitive decline, particularly in older adults. By analyzing driving behaviors and performance, the study aims to create a non-invasive and cost-effective method for detecting Mild Cognitive Impairment (MCI) before it progresses to more severe forms of dementia like Alzheimer's Disease. The approach focuses on capturing driving signatures that reflect cognitive challenges faced in everyday situations, providing a potential early intervention point for lifestyle changes. This innovative method seeks to improve the quality of life for seniors by enabling timely detection and intervention.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of cognitive decline, allowing for timely interventions that may delay or prevent the progression to dementia.
How similar studies have gone: Previous research has shown promise in using behavioral assessments, including driving performance, to detect early cognitive decline, suggesting that this approach could be effective.
Where this research is happening
-
Tf Health Corporation
Fountain Hills, United States Active
Researchers
- Principal investigator: Tsow, Francis — Tf Health Corporation
- Study coordinator: Tsow, Francis
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
NGF Metabolism as a biomarker for cognitive decline in familial Alzheimer's disease
Researchers are studying whether patterns in nerve growth factor pathways in blood and CSF can signal early, preclinical stages of Alzheimer's in people with genetic risk.
-
NGF metabolism as an early biomarker for cognitive decline in familial Alzheimer's disease
This project tests whether NGF pathway proteins in blood and CSF can signal early, preclinical changes in people with familial Alzheimer’s disease.
-
NGF Metabolic Dysfunction as a Marker of Cognitive Decline in Autosomal Dominant Alzheimer's Disease
This project looks at nerve growth factor pathways in people with a genetic form of Alzheimer's to see if blood and spinal fluid markers can identify early brain changes before symptoms appear.
-
Optimizing a closed-loop digital meditation to help cognitive aging and stress in older adults
A mobile, personalized meditation program is being tested to help older adults maintain thinking skills and lower stress.
-
Cash transfers in South Africa to reduce dementia risk in later life
This project tests whether government cash transfers in rural South Africa help protect people’s thinking and memory as they age.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.